TGF-β levels after the intervention also showed statistically significant negative correlations with TCNSs both before (r = −0.320; p = 0.048) and after the intervention (r = −0.353; p = 0.033), indicating that higher TGF-β levels following the intervention were associated with lower TCNSs, reflecting reduced neuropathy symptoms (Table 5). The gene discussed is TGFB1; the disease is neuropathy.